MoneyWorks4Me

Alembic Pharmaceuticals raises Rs 150 crore via NCDs

19 Mar 2019 Evaluate

Alembic Pharmaceuticals has raised Rs 150 crore through allotted of 1,500 at 8.37% Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of Rs 10 lakh per NCD under Tranche III. The NCD Committee of the Company at its meeting held on March 19, 2019 has allotted the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1869.80
Dr. Reddys Labs. 1200.00
Cipla 1382.50
Lupin 2119.90
Zydus Lifesciences 1165.00
View more..